Suzanne Martin-Mouries
14, Rue Paul Gaffarel
Dijon, 21000, France
Dijon, 21000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Serum interferon-beta level determined by an ultrasensitive electrochemiluminescence immunoassay is increased in clinically active and inactive systemic lupus erythematosus.
Journal: European cytokine network
Published: June 13, 2025
Colchicine and non-severe ocular inflammation excluding Behcet's disease: 16 cases and literature review
Journal: La Revue de medecine interne
Published: May 11, 2022
Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α.
Journal: Annals of the rheumatic diseases
Published: March 26, 2022
Correction to: The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome.
Journal: Journal of translational medicine
Published: March 09, 2021
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome.
Journal: Journal of translational medicine
Published: October 20, 2020
Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse.
Journal: Annals of the rheumatic diseases
Published: April 18, 2019
Monitoring Disease Activity in Systemic Lupus Erythematosus With Single-Molecule Array Digital Enzyme-Linked Immunosorbent Assay Quantification of Serum Interferon-α.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: December 18, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026